Author: CBD-Intel
CBD-Intel regulatory news in brief, 9th-15th October
Written by CBD-Intel || 15th October 2021 || Regulatory alerts roundup |
This week's regulatory news in brief includes updates from Germany, Ireland, the US, Chile, Malaysia, Nepal, New Zealand, Panama and Pakistan ...
New Moroccan government will stick with medical cannabis production plan
Written by CBD-Intel || 14th October 2021 || Regulatory briefing |
Morocco’s new medical cannabis law is still supported by the new government of Aziz Akhannouch, even though it was the pet project of a minister in the government he has displaced ...
Is CBD a dietary ingredient or a drug? US FDA ‘appears to have changed its mind’
Written by CBD-Intel || 13th October 2021 || Regulatory briefing |
The lack of a clear regulatory pathway to market for CBD products in the US is highlighted by a row over the FDA’s denial of new dietary ingredient (NDI) approval for full spectrum hemp extracts ...CBD-Intel regulatory news in brief, 2nd-8th October
Written by CBD-Intel || 8th October 2021 || Regulatory alerts roundup |
This week's regulatory news in brief includes updates from Spain, US, Mexico, Argentina, Chile, Malaysia and New Zealand ...
German medical cannabis imports rise but no sign of domestic production yet
Written by CBD-Intel || 8th October 2021 || Business briefing |
German imports of medical cannabis flowers rose by 80% in the first half of 2021 compared to the same period of 2021, but hopes of establishing local production were...
Thailand expecting massive returns from economic zone cannabinoid pilot
Written by CBD-Intel || 8th October 2021 || Business briefing |
Thailand’s government is allowing farmers in the country’s Eastern Economic Corridor (EEC) to use 10,000 rai of undeveloped land to grow cannabis, hemp, and other medicinal herbs to help boost the economy and farmer's standard of living ...
Zimbabwe fails to live up to its cannabis ambitions as licences lie dormant
Written by CBD-Intel || 6th October 2021 || Business briefing |
Zimbabwe wants to be a big player in the African cannabis industry, but the country is failing to meet its initial ambitions because only a few licensed companies are active ...
Panama leads the way with Central America’s first legal medical cannabis
Written by CBD-Intel || 5th October 2021 || Regulatory briefing |
Panama is set to become the first country in Central America to legalise and regulate medicinal cannabis after the 44-member National Assembly voted unanimously in favour of doing so ...CBD-Intel regulatory news in brief, 25th September-1st October
Written by CBD-Intel || 1st October 2021 || Regulatory alerts roundup |
This week's regulatory news in brief includes updates from Czech Republic, Germany, Ireland, Spain, Portugal, the US, Ecuador, Malaysia and Thailand ...
Gloomy US outlook for CBD production as regulatory uncertainty strangles farms
Written by CBD-Intel || 30th September 2021 || Business briefing |
A lack of regulatory clarity is the primary reason behind a predicted dramatic fall in hemp acreage dedicated to the production of CBD in the US ...
Why do cannabis black markets persist in US states where recreational use is legal?
Written by CBD-Intel || 27th September 2021 || Business briefing |
Although many point to tax rates driving legal prices higher than those on the illicit market, access plays a bigger role than price in the survival of cannabis black markets, according to experts ...CBD-Intel regulatory news in brief, 18th-24th September
Written by CBD-Intel || 24th September 2021 || Regulatory alerts roundup |
This week's regulatory news in brief includes updates from Germany, Hungary, Italy, Lithuania, Spain, the US, Colombia and...
Resistant legislators deny Kentucky and Tennessee access to medical cannabis
Written by CBD-Intel || 21st September 2021 || Regulatory briefing |
Kentucky and Tennessee are among a large number of Southeastern US states that have not yet passed legislation for medical cannabis programs. Here, CBD-Intel examines the issues behind the official reluctance ...
Lidl has a change of heart, removing edible hemp products from its shelves
Written by CBD-Intel || 21st September 2021 || Business briefing |
Discount supermarket chain Lidl has removed foods containing hemp from its stores in Germany, Ireland and the Netherlands amid concerns that the products contain excessive levels of THC ...CBD-Intel regulatory news in brief, 11th-17th September
Written by CBD-Intel || 17th September 2021 || Regulatory alerts roundup |
This week's regulatory news in brief includes updates from Czech Republic, EU, Finland, Ireland, Italy, Portugal, Spain, UK, US and Costa Rica ...
NFL vet claims orange-peel CBD ‘purer’ than cannabis or hemp-derived products
Written by CBD-Intel || 13th September 2021 || Business briefing |
NFL veteran Chris Hetherington has launched a CBD oil derived entirely from orange peel, describing it as “crystalline CBD at a purity and consistency difficult to match with cannabis or hemp-derived material” ...CBD-Intel regulatory news in brief, 4th-10th September
Written by CBD-Intel || 10th September 2021 || Regulatory alerts roundup |
This week's regulatory news in brief includes updates from Belgium, Ireland, Italy, UK, US, China, Namibia, Nigeria and Zimbabwe ...
Beverage brands still searching for the right solution to their drink problem
Written by CBD-Intel || 9th September 2021 || Blog , Business briefing |
CBD beverages continue to be a popular niche sub-category for producers, with brands still experimenting and bringing out new variations. Some significant regulatory concerns remain for the mid/long-term. Neither the US, UK or EU has explicitly permitted CBD...
Smokable hemp ban in Texas overturned but further court action is probable
Written by CBD-Intel || 7th September 2021 || Regulatory briefing |
A ban on the production and sale of smokable hemp products in Texas has been fully overturned after two court decisions – but the case will almost certainly head through two further levels of appeal ...
CBD-Intel global alerts database September
Written by CBD-Intel || 6th September 2021 || Regulatory alerts roundup |
All the stories from the CBD-Intel weekly global regulatory Live Alerts in one user-friendly database, updated every month.This regulatory tool consolidates all of our global regulatory Live Alerts since they were launched in May 2019, collected in Excel...CBD-Intel regulatory news in brief, 28th August-3rd September
Written by CBD-Intel || 3rd September 2021 || Regulatory alerts roundup |
This week's regulatory news in brief includes updates from Italy, Germany, Portugal, Spain, Mexico, the US, Belize, China, Colombia, Japan, Malaysia, Panama, South Africa, Thailand and Uruguay ...
Lagging behind: why Wyoming and Idaho are still to legalise medical cannabis
Written by CBD-Intel || 3rd September 2021 || Regulatory briefing |
There are now only 14 US states that have yet to implement a medical cannabis programme. Why they are behind the curve on the issue is something of a mystery ...
Approved by EU – so why was Finola hemp tested and banned in Poland?
Written by CBD-Intel || 2nd September 2021 || Regulatory briefing |
Crops of a hemp variety found by Polish authorities to be over the THC limit should never have been tested and regulators are refusing to say why they were, the creator of the variety alleges ...
Could Colombia’s reversal on allowing medical cannabis flower exports impact the global market?
Written by CBD-Intel || 1st September 2021 || Blog , Regulatory briefing |
There are always people claiming that new changes mean some such country will be "The next big X in cannabis or hemp". Recent examples include North Macedonia, Thailand, Brazil, Paraguay, Lesotho, Malawi, and of course, Colombia ...
Horse sense or dog trial? The science and law behind CBD petcare products
Written by CBD-Intel || 1st September 2021 || Business briefing |
CBD pet products remain in a grey area in terms of both legality and effectiveness – but there have been some attempts in both to shed light into the darkness ...CBD-Intel regulatory news in brief, 21st-27th August
Written by CBD-Intel || 27th August 2021 || Regulatory alerts roundup |
This week's regulatory news in brief includes updates from Bosnia and Herzegovina, Croatia, Germany, Spain, Switzerland, the US, Costa Rica, Morocco and Panama ...
‘Transcendental change’ as president opens up Colombia to flower exports
Written by CBD-Intel || 26th August 2021 || Business briefing |
“Today, Colombia eliminates the prohibition of dried flower exports,” president Iván Duque said. “This means that Colombia will enter and participate in the international market in a big way.” ...
Brazil’s bill to legalise hemp and medical cannabis runs into a further snag
Written by CBD-Intel || 24th August 2021 || Regulatory briefing |
A bill to legalise the cultivation and processing of hemp and medical cannabis in Brazil has been dealt a blow with a call for it to be debated and voted on by the country’s full Chamber of Deputies...
Positive regulatory changes for CBD, hemp and cannabis in Uruguay
Written by CBD-Intel || 23rd August 2021 || Regulatory briefing |
Uruguay is expected to become one of the first countries to officially legalise the use of CBD in ingestible products ...CBD-Intel regulatory news in brief, 14th-20th August
Written by CBD-Intel || 20th August 2021 || Regulatory alerts roundup |
This week's regulatory news in brief includes updates from the EU, Germany, the US, Fiji and Japan ...
Legislators propose bringing Polish hemp laws in line with other EU states
Written by CBD-Intel || 20th August 2021 || Regulatory briefing |
Lawmakers from Poland’s ruling party are among those who have submitted two bills to parliament hoping to change the country’s industrial hemp growing and medical cannabis legislation ...
The entourage effect: new studies could help to explain the phenomenon
Written by CBD-Intel || 18th August 2021 || Business briefing |
Two new studies on the biochemistry of cannabinoids could provide answers to a puzzling question – how does the entourage effect work? ...CBD-Intel regulatory news in brief, 7th-13th August
Written by CBD-Intel || 13th August 2021 || Regulatory alerts roundup |
This week's regulatory news in brief includes updates from Netherlands, Spain, Poland, the US and Guyana ...
Medical use of psilocibyn in Canada could grow, but consumer sale unlikely
Written by CBD-Intel || 13th August 2021 || Regulatory briefing |
A court case could force the Canadian government to process requests to use psilocybin for psychotherapeutic treatment more...
Testing the testers: UK and US CBD testing labs go under the microscope
Written by CBD-Intel || 13th August 2021 || Regulatory briefing |
A recent ring trial assessment of the lab performances and methods for measuring CBD in commercial products has given some good news to the industry ...
Spain’s PSOE has a change of heart over legalising medical cannabis
Written by CBD-Intel || 11th August 2021 || Regulatory briefing |
Members of Spain’s ruling party are warming to the idea of legalising medicinal cannabis just months after claiming scientific evidence was insufficient to support such an initiative ...
Test-tube cannabinoids: scientists seek alternatives to agricultural production
Written by CBD-Intel || 11th August 2021 || Business briefing |
New methods for laboratory production of cannabinoids show some promise – but it’s still not clear whether they will yield enough to be commercially viable ...
New regulations spell positive steps for Thailand’s cannabis and hemp industry
Written by CBD-Intel || 9th August 2021 || Regulatory briefing |
A series of changes in Thai law governing both medical cannabis and hemp has made the country one of the most cannabinoid-friendly countries in Asia ...
Firm announces mushroom tinctures to launch in UK under Bob Marley brand
Written by CBD-Intel || 9th August 2021 || Business briefing |
A range of Bob Marley themed functional mushroom tinctures will soon debut in the UK under the Marley One brand ...CBD-Intel regulatory news in brief, 31st July-6th August
Written by CBD-Intel || 6th August 2021 || Regulatory alerts roundup |
This week's regulatory news in brief includes updates from Spain, the UK, the US, Australia, Colombia, Costa Rica, Ecuador and Israel ...
Study raises early hopes for the use of CBD in treating nicotine withdrawal
Written by CBD-Intel || 5th August 2021 || Business briefing |
Researchers at the University of San Diego in California have published a paper showing early evidence that CBD may help ease the symptoms of nicotine withdrawal ...CBD-Intel regulatory news in brief, 24th-30th July
Written by CBD-Intel || 30th July 2021 || Regulatory alerts roundup |
This week's regulatory news in brief includes updates from Czech Republic, Germany, Spain, the US and...
US Postal Service ponders the post-PACT legality of continuing to ship CBD vapes
Written by CBD-Intel || 29th July 2021 || Regulatory briefing |
The US Postal Service (USPS) is still shipping CBD vape products for now – but the latest version of the Prevent All Cigarette Trafficking (PACT) Act leaves a lot of uncertainty over the exact legal position...CBD-Intel regulatory news in brief, 17th-23rd July
Written by CBD-Intel || 23rd July 2021 || Regulatory alerts roundup |
This week's regulatory news in brief includes updates from Belgium, Ireland, Italy, the US and South Korea ...
Lobbyists for ‘special interests’ accused of un-American activities on cannabis
Written by CBD-Intel || 23rd July 2021 || Business briefing |
Licensing issues look set to become the next big US lobbying battleground for cannabis as money moves on from the traditional legalisation-versus-prohibition field ...
Company behind the UK’s first medical cannabis vape aims to lead a revolution
Written by CBD-Intel || 22nd July 2021 || Business briefing |
London-listed Kanabo has launched the first medical cannabis vaping product in the UK in a move the company’s founder hopes will ultimately revolutionise the way medicines are administered ...
Malawi set for its first hemp harvest following legalisation and licensing
Written by CBD-Intel || 20th July 2021 || Business briefing |
Malawi is set to have its first hemp harvest this year following the licensing of 36 companies. However, despite hopes the plant could change the country’s economic fortunes, it will continue to be strictly regulated ...
Javid appointment as UK health minister raises slight hope for medical cannabis
Written by CBD-Intel || 19th July 2021 || Regulatory briefing |
Medical cannabis advocates are keen to see if Sajid Javid’s appointment as UK health secretary means he will continue his work from 2018, when he helped change the law on medicinal cannabis prescriptions ...